Skip to content
Research & community

MS research, together.

MS research in plain English. Perspectives from people who understand.

Research evidence filters

Filters apply to published research with a structured evidence assessment, including clearly labelled summaries that have not yet had human review. Unknown dates and unassessed posts are excluded when a corresponding filter is active.

Reset filters
Topics & sourcesFiltered
Research and community updates, newest first.#RemyelinationAI researchClear filters
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyAnimal studyNot reportedPublished in a peer-reviewed journal

Effects of GPR17 Antagonist in Isolated Rat Oligodendrocyte Precursor Cells

In this study, isolated rat oligodendrocyte precursor cells (OPCs) were treated with the GPR17 antagonist 22 (10 μM), which led to an increase in MBP expression and a growth in Olig2+ cells.

What this does not proveThe study does not establish clinical efficacy in humans or report on primary endpoints.
View abstract on PubMedPMID 42916681AI summary of a published abstract. Not medical advice.